Pharmacetical Newswire

Pharmaceutical News!

Press release distribution service
Pharmaceutical Links

Pharmanewswire.Com: Pharmaceutical News

Aerosol Treatment Market Research Report 2028 -Market Size and Forecast

(PharmaNewsWire.Com, September 16, 2021 ) Market Overview

Aerosol treatment is the approach used to manage the drugs immediately into the lungs and their airlines. It is mostly a suspension of beverages or solids administered the usage of a scientific device which includes an inhaler.



View full report: https://bit.ly/3AfikLC



Market Dynamics

The aerosol treatment market growth is driven by the increasing prevalence of chronic respiratory conditions such as COPD, asthma, and pneumonia, the main advantage of the aerosol treatment is the usage of smaller doses, giving rapid response with minimal side effects. The diversified use of aerosol treatment to treat different indications and additional therapeutic effects is driving the growth of the aerosol treatment market.



The increasing prevalence of chronic respiratory diseases is expected to drive the growth in the forecast period

The major respiratory disorders currently cured using aerosol treatment include Asthma, COPD, Bronchiectasis, cystic fibrosis, pulmonary arterial hypertension, and infectious pulmonary diseases. As per the Center for Disease Control and Prevention (CDC), around 16 million people suffer from COPD. As per CDC, in the last decade, the prevalence of asthma in the U.S. has increased by 15%. For example, 3.8 million people in Canada had asthma, and 2.0 million had chronic obstructive pulmonary disease (COPD) in 2018. Respiratory diseases also lead to lost productivity and healthcare costs. The increasing burden of these diseases needs rapid intervention by increasing better treatment.



Side-effects associated with aerosol treatment is likely to hinder the market growth

A few reported adverse cases of oral candidiasis in patients who use aerosol treatment may hamper the growth of the market.



Segment Analysis

By Product Type

Nebulizers

Metered-dose inhalers

Dry powder inhalers

By Application

Asthma

Chronic obstructive pulmonary disease

Cystic fibrosis

By End-User

Hospitals

Clinics

Ambulatory Surgical Centers



Download free sample: https://bit.ly/3tK3Gta



Geographical Analysis

North America region holds the largest market share of the global aerosol treatment market



North America region is dominating the global aerosol treatment market accounted for the largest market share. As the population in the region follows a fast-moving lifestyle, patients are looking for more inhalers that can be transferred easily in a time of need for patients suffering from asthma and other airway diseases.



In addition, healthcare cost containment issues, the post-economic crises in the United States, have required the government to introduce new strategies to reduce patient stays in hospitals. This provided the impetus to homecare services, which in turn, created a favorable environment for the growth of the aerosol treatment market.



Competitive Landscape

The global aerosol treatment market is highly competitive with the presence of global companies. Some of the key players which are contributing to the growth of the market include Merck, Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, Teva Pharmaceuticals, Opko Health, Omron Healthcare, Medtronic, GE Healthcare. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the market globally.



Related Topic's

Atomic spectroscopy Market, Automatic Pill Dispenser Market, Cancer Biopsies Market, Weight loss stomach pump Market, Dermatophytic Onychomycosis Therapeutics Market

DataM Intelligence

Sai Kiran

+1 877 441 4866

pr@datamintelligence.com

Source: EmailWire.Com

Source: EmailWire.com


Pharmaceutical Sponsors

Free Biotech & Pharmaceutical Magazines

Pharmacy Newswire Video Feed

Pharmaceutical & Biotech Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:

IronPort Provides Email Management and Analysis for a Premier Health Care Solutions Provider
Pharmaceutical & Medical Packaging News
Medical Laboratory Observer

No credit cards, coupons, or promo codes required. Try it today!

Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com, or contact us.
Copyright 2009 GroupWeb Media LLC
GroupWeb Media Network

Aviation-NewsWire | ArtNewsWire | Auction NewsWire | CRM NewsWire | ePhotoNewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | i-Homeland Security.Com | iMac-NewsWire.Com | i-Press-Release-Service | i-SoftwareNews.com | iT-NewsWire.Com
| i-TravelNewsWire.Com | MoneyNewsWire.Net | Movie-Stars-News.Com | MSNewsWire.Net | PharmaNewsWire.Com | Publishing-NewsWire.Com | RSSNewsWire.Net | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com | VoIPNewsWire.Net | XSportsWorld.Net
Pharmanewswire.com - Pharmaceutical Newswire and Press Release service of GroupWeb Media LLC